Skip to main content
. Author manuscript; available in PMC: 2021 Nov 15.
Published in final edited form as: Clin Cancer Res. 2021 Mar 3;27(10):2910–2919. doi: 10.1158/1078-0432.CCR-20-4367

Figure 1.

Figure 1.

Oncoprint figure showing patient and tumor characteristics, immunohistochemical analyses, germline and somatic FH alterations, loss of heterozygosity and co-occurring gene alterations.